Illumina's Entry to Shake Up the US NIPD Market Landscape
As per the new research report by RNCOS, “US Non-Invasive Prenatal Diagnostics - Market Insight”, the market for non-invasive prenatal diagnostics in US is expanding at a rapid rate, the latest entrant in the market being Illumina. Illumina has acquired Verinata Health for US$ 350 Million. Its entry into the market is expected to drastically modify the market landscape. Even Sequenom, the current leader in the NIPD market space, is dependent on Illumina’s next generation sequencing solutions for performing the...
View full press release